This grant provides resources to establish a new MIBG therapy program to treat neuroblastoma, an aggressive childhood cancer which can be difficult to treat. This treatment has been shown to help children with relapsed neuroblastoma and is now being used in newly diagnosed high risk patients.

Based on progress to date, Dr. Fish was awarded a new grant in 2011 to fund an additional two years of this Scholar award. Since over 75% of children with cancer can now be cured, the population of 250,000 survivors of childhood cancer in the USA is rapidly growing. Over 60% of survivors have a chronic medical problem, and 27% a severe or life-threatening problem as a result of their treatment. Research into problems faced by survivors is critical to improving their care. Dr. Fish investigates whether care in a specialized center will improve: 1) patient awareness of treatments they received and risks they face because of those treatments; and 2) the ability of survivors to follow medical recommendations and referrals.